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ABSTRACT 
This work describes two experimental studies performed 
for my doctoral thesis. The general subject is the analysis 
of the features and mechanisms of protein synthesis in 
extremely thermophilic Archaea. The subject is 
interesting and relevant from different points of view. 
Firstly, it has long been known that archaeal translation 
shares several features and components with the 
corresponding eukaryal process. Investigating the 
common themes between archaeal and eukaryal protein 
synthesis may help to shed light on the evolutionary 
origin thereof and to reconstruct the pathways whereby 
Eukarya emerged from the common tree of life. 
Secondly, extremely thermophilic Archaea have a lot of 
potential for biotechnological development, for instance 
as a source of thermostable enzymes to be used for both 
medical and industrial purposes. 
In the first part of my work, I shall describe a functional 
analysis of the archaeal translation factor aIF6, a protein 
shared by the Archaea and the Eukarya but not found in 
Bacteria. Although the eukaryal factor (eIF6) has been 
studied extensively, its function in translation is still 
imperfectly understood. It is established that it acts as a 
ribosome anti-association factor, binding to the large 
subunit and preventing its premature joining with the 
small subunit. To allow the 60S ribosome to enter the 
translation cycle, eIF6 must be actively released, a 
process that depends on the action of another factor, 
Sdo1/SBDS, which is also found in Archaea, and of a 
GTPase, EFL1, that instead does not have an archaeal 
homologue. In my work, I studied the mechanism of aIF6 
release from archaeal large ribosomal subunits, using as 
the model organism the thermophilic archaeon Sulfolobus 
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solfataricus. The results I obtained show that detachment 
of aIF6 from ribosomes requires the GTPase activity of 
elongation factor 2 (aEF2), while the Sdo1/SBDS 
homologue apparently inhibits rather than promoting 
aIF6 release. The function of archaeal Sdo1 remains 
therefore to be understood and must be studied further. 
In the second part of work, I developed a coupled in vitro 
transcription/translation system for cell-free protein 
synthesis from cell lysates of S. solfataricus. The 
essential element in this expression system is a strong 
promoter derivedfrom 16S/23S rRNA-encoding DNA 
promoter from the archaebacterium Sulfolobus sp. P2 
thatproduces, with high efficiency, specific mRNAs. I 
show thatthis method permits the efficient synthesis in 
vitro at high temperature of biologically active proteins.  
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1. GENERAL INTRODUCTION 
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1.1 Archaea 
The Domain Archaea was not recognized as a major 
domain of life until quite recently. Until the 20th century, 
most biologists considered all organisms to be 
classifiable as either a plant or an animal. But in the 
1950s and 1960s, most biologists came to the realization 
that this system failed to accommodate the fungi, protists 
and bacteria. By the 1970s, a system of Five Kingdoms 
had come to be accepted as the model by which all living 
things could be classified. At a more fundamental level, a 
distinction was made between the prokaryotic bacteria 
and the four eukaryotic kingdoms (plants, animals, fungi 
and protists). The distinction recognizes the common 
traits that eukaryotic organisms share, such as nuclei, 
cytoskeletons, and internal membranes. But the 
eukaryote-prokaryote concept is fundamentally 
cytological, and only secondarily phylogenetic. The 
presumption that the eukaryotic form of cellular 
organization defines a meaningful phylogenetic unit is a 
reasonable one. The same is unfortunately not true of 
prokaryotes, which are united as a class by their lack of 
the characteristics that define the eukaryotic cell.  Thanks 
to the sequencing revolution, by making accessible the 
vast store of historical information contained in 
molecular sequences, the basis for systematic has 
changed and the classical phenotypic criteria are being 
replaced by molecular criteria. In the late 1970s, by 
means of molecular analysis, the scientific community 
remained surprised by the discovery of an entirely new 
group of organisms: Archaea. Carl Woese and his 
colleague George E. Fox, at the University of Illinois, 
were studying the relationships among the prokaryotes 
using ribosomal RNAs (rRNAs), the essential 
components of the protein synthetic machinery that are 
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encoded by all prokaryotic genomes and in characteristic 
distinct versions, by eukaryotic nuclear, mitochondrial 
and chloroplast genomes. They found that the 
prokaryotic domain, far from being unitary, was split into 
two distinctly different groups (Woese and Fox,1977): 
certain micro-organisms that lived at high temperatures 
or produced methane clustered together as a group well 
away from the common bacteria and from the eukaryotes 
as well. Because of this vast difference in genetic 
makeup, Woese proposed that life be divided into three 
main domains: Eukaryota, Eubacteria, and 
Archaebacteria. He later decided that the term 
Archaebacteria was a misnomer, and renamed it to 
Archaea. At the cytological level, Archaea are indeed 
prokaryotes (they show none of the defining eukaryotic 
characteristics), but on the molecular level (ribosomal 
proteins, translation factors, RNA polymerase, etc.) they 
resemble other prokaryotes, the eubacteria, no more than 
they do the eukaryotes. 
A “universal tree of life” based on comparison of rRNA 
sequences is shown in Fig. 1. Although the studies 
involving rRNA sequences produce the topology of the 
universal tree, they do not indicate the position of its 
root. However, it is in principle possible to root the 
universal tree using pairs of related (paralogous) genes 
with distinct functions (Schwarz and Dayhoff, 1978) 
whose common ancestor duplicated in the ancestral 
lineage before the three primary lines of descent came 
into being (e. g. genes coding for translation elongation 
factors, ATPase subunits, aminoacyl-tRNA synthetases, 
components of the protein-targeting machinery). 
Different phylogenetic investigations give the same 
results: the root lies between the bacteria and the other 
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two primary lines of descent, which are, thus, sister 
domains sharing a last common ancestor (Fig. 1). 
 
 
Fig. 1 Rooted Universal Phylogenetic Tree of Life. (Adapted from 
Woese, 1990). 
 
That the Archaea and Eucarya have indeed shareda 
common evolutionary path has been proven by the recent 
analyses of complete genomic sequences. These have 
shown that the Archaea and the Eucarya share sequence 
homologies in many genes, especially those encoding 
components of the gene expression machinery. One 
example of this evolutionary proximity is given by the 
transcription apparatus. The RNA polymerases of 
Eucarya and Archaea resemble each other in subunit 
composition and sequence far more than either resembles 
the bacterial type of polymerase. Moreover, whereas all 
bacterial cells use sigma factors to regulate the initiation 
of transcription, eukaryal and archaeal cells use TATA-
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binding proteins (Langer D. et al., 1995). Other examples 
ofsimilarities occur in the initiation of archaeal protein 
synthesis, which makes use of non-formylated 
methionyl-tRNA; in addition, many archaeal tRNA genes 
resemble their eukaryal homologs in harbouring introns. 
Moreover, all Archaea have genes encoding homologues 
of most eukaryotic translation initiation factors (Kyrpides 
and Woese, 1998). 
 
1.1.1 Classification 
Archaea include inhabitants of some of the most extreme 
environments on the planet. Some of them live near rift 
vents in the deep sea at temperatures over 100 °C, others 
in hot springs or in extremely alkaline or acid waters. 
They have been found thriving inside the digestive tracts 
of cows, termites, and the marine life where they produce 
methane. They live in the anoxic muds of marshes and at 
the bottom of the ocean, and even thrive in petroleum 
deposits deep underground. In spite of these 
environmental differences, Archaea represents a 
phylogenetically coherent group. From a phenotypic 
point of view, Archaea are known to comprise four quite 
distinct general groups: the methanogens, the extreme 
halophiles, a loosely defined thermophilic (“sulphur-
dependent”) type, and thermophilic sulphate reducers.   
However, the four major phenotypes do not correspond 
to four distinct taxa of equivalent rank. According to the 
rRNA tree, there are two main branches, corresponding 
to the kingdoms of Crenarchaeota and Euryarchaeota 
(Woese et al., 1990). The formers are relatively 
homogeneous phenotypically, consisting of 
hyperthermophiles or thermoacidophiles (Sulfolobus, 
Desulfurococcus, Pyrodictium, Thermoproteus and 
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Thermofilum. The Euryarchaeota, on the other hand, 
constitute an heterogeneous kingdom including 
hyperthermophiles (i.e. Pyrococcus and Thermococcus), 
methanogens (such as Methanosarcina ), 
halophiles(some genera are Halobacterium and 
Haloferax ) and, last but not least, thermophilic 
methanogens (some genera are Methanococcus, 
Methanobacterium and Methanotermus). About twenty 
years ago, PCR analysis of hot spring microbiota 
detected new archaeal rRNA sequences that branch either 
deeply within the Crenarchaeota or just below the 
Crenarchaeota-Euryarchaeota divergence (Barneset al., 
1994). These organisms have been assigned to a third 
kingdom, the Korarchaeota (Barneset al., 1996).  
Furthermore, it was found a new nanosized 
hyperthermophilic archaeon from a submarine hot vent. 
This archaeon cannot be attached to any of the known 
groups and therefore must represent an unknown phylum, 
termed Nanoarchaeota.Cells of Nanoarchaeota equitans 
specie are spherical, and only about 400 nm in diameter. 
They grow attached to the surface of a specific archaeal 
host and harbor the smallest archaeal genome: only 0.5 
megabases in size (Huber et al., 2002).  
15 
 
1.2 Archaeal cell biology: genome structure and gene 
expression 
Although the cellular structure of Archaea resembles the 
bacterial one, consisting of   a single cell without both the 
nuclear membrane and the cytoplasmic organelles, many 
morphological and metabolic characteristics are 
distinctive of this kingdom and single the Archaea out of 
all other organisms. Archaeal membrane lipids are 
unique in consisting of ether-linkages established 
between glycerol and hydrocarbon chains, while bacteria 
and eukaryotes have esters linkages (Kates, 1993). Also, 
the nature of the layers surrounding the cells differs 
distinctly from that of bacteria and shows remarkable 
structural and chemical diversity. The Bacteria 
(eubacteria) except for the Chlamydias, have a semirigid 
cell wall containing peptidoglycan.   Among the Archaea, 
a cell wall is only found in the order Methanobacteriales; 
however, it differs from the bacterial one in containing 
pseudomurein instead of the conventional murein 
(Kandler, & Koenig, 1993). Moreover, Archaea generally 
lacking a peptidoglycan cell wall possess surface layers 
(S-layers) that consist of protein or glycoprotein subunits. 
The archaeal chromosomes so studied have revealed a 
single circular double helix of DNA covalently closed 
(Keeling et al., 1994) whose size is included between 1,7 
and 5 Mb, except for Nanoarcheum equitans, with a 
genome of around 0,5 Mb (Huber et al., 2002). Similar to 
Bacteria lacking a nuclear membrane, Archaea have their 
genomes organized into a nucleoid, but the architectural 
proteins that form the nucleoid are largely different. 
Genomic DNA is packaged into archaeal nucleosomes, 
which contain an archaeal histone tetramer circumscribed 
by ~80 bp of DNA. Archaeal histones are not present in 
Crenarchaeota but are present in most Euryarchaeota 
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and resemble in their tetrameric structure the complex 
formed by the (H3 + H4)2 histone tetramer at the centre 
of the eukaryal nucleosome (Pereira et al., 1997; Bailey 
et al., 1999). Similar to Bacteria, and unlike Eukarya, 
clusters of contiguous genes functionally coordinated 
tend to be organized in cotranscribed units, producing 
polycistronic mRNAs. Interestingly, the mosaic nature of 
archaeal genomes is reflected in the operons themselves, 
in which there are some genes homologous to genes 
found in bacteria while other homologous to genes found 
in eukaryotes (Ouzounis and Kyprides, 1996). Protein-
coding genes are not endowed with introns, while these 
elements have been detected in some RNA-coding genes. 
For example, in Sulfolobus solfataricus, introns have 
been found in six tRNA (She et al, 2001). Archaeal 
tRNA introns are similar to those of eukaryotes (located 
one nucleotide 3’ to the anticodon (Lykke-Andersen et 
al. 1997; Belfort and Weiner, 1997) but neither group I 
nor group II self-splicing introns have been reported in 
Archaea, despite their existence in both Bacteria and 
Eukaryotes. Moreover, similarly to Eukaryote and 
Bacteria, Archaea contain inteins, genetic elements 
present in protein-coding sequences that following 
translation efficiently remove themselves from the host 
protein in an autoproteolytic protein-splicing reaction and 
re-ligate their two flanks. Concerning the replication, 
many archaeal DNA replication proteins are more similar 
to those found in Eukarya than Bacteria, including those 
involved in the initiation process (Grabowski and 
Kelman, 2003). This suggests that the archaeal origins of 
replication, their recognition by initiation factors, and the 
initiation process are also similar to Eukarya. The first 
archaeal origins were identified using in silico analysis, 
showing a single origin in some Archaea and multiple 
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origins in others (Grigoriev, 1998; Salzberg et al., 1998). 
The identified origins are rather large, and many are 
located in close proximity of the genes encoding the 
archaeal homolog of the eukaryotic initiator protein 
Cdc6, although the proximity of origin to the Cdc6 gene 
is not essential for origin function and is not a universal 
phenomenon in the Archaea domain. In silico studies 
were confirmed by detailed in vivo analysis 
demonstrating the presence of single origins of 
replication in some species such as Pyrococcus abyssi 
(Myllykallio et al., 2000; Matsunaga et al., 2001) and 
Archeoglobus fulgidus(Maisnier-Patin et al., 2002) and 
multiple origins of replication in the chromosome of 
Sulfolobus solfataricus and Sulfolobus acidocaldarius 
(Robinson et al., 2004; Lundgren et al., 2004).  Finally, 
as regards the transcriptional apparatus, Archaea 
resemble more closely the Eukaryotes than the Bacteria. 
Archaea do posses a single RNA Polymerase (RNAP) 
like the Bacteria, but the subunit composition of the 
archaeal enzyme is far more complex than that of 
bacterial RNAPs (Keeling and Doolittle, 1995); 
accordingly, the primary sequence of several archaeal 
RNAP subunits is closer to that of the eukaryal 
polypeptides than to that of the bacterial one. The 
archaeal RNAP, like the eukaryal one, is unable to 
efficiently recognize promoter sequences on its own and 
requires two additional basal factors: the TATA-box-
binding protein (TBP) and transcription factor B (TFB), 
homologues of eukaryal TBP and of transcription factor 
IIB (TFIIB) respectively (Bell and Jackson, 1998). The 
archaeal promoter resembles in sequence and position the 
eukaryal RNA polymerase II promoter, which includes a 
TATA[A/T]A sequence placed approximately 20-30 
bases upstream of the transcription start point. In the 
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Archaea, the TATA box of the eukaryotic promoter is 
replaced by a “box A” sequence (TTTA[A/T]A) located 
approximately 27 bp upstream from the transcription start 
site. 
1.3 Protein Synthesis 
The degree to which the components of the three major 
cellular systems (replication, transcription and 
translation) are conserved in evolution differs greatly. On 
one side there is genome replication as depicted above, 
where not even the central DNA polymerase is 
orthologous between the Bacteria and the 
Archaea/Eucarya. On the other side there is translation, 
where many components are well conserved in all 
domains: ribosomal RNAs, the tRNAs and the elongation 
factors. Translation by the ribosome is traditionally 
divided into several separate steps: initiation, elongation, 
termination and recycling.  All of these steps are aided by 
translation factors, which accordingly, are called 
initiation, elongation, release and recycling factors. At 
least ten protein factors participate in bacterial 
translation, whereas a considerably larger number is 
needed in eukaryotic organisms (Sachs et al., 1997; 
Dennis, 1997). Several of these factors are GTPases, 
usually activated after binding to the GTPase centre of 
ribosome. Translation factors and tRNAs bind to the 
ribosome transiently and move between different binding 
sites. The ribosomal tRNA binding sites are the decoding 
A-site, where amino acyl tRNA binds, the P-site, where 
the peptidyl tRNA binds, and the E-site, where 
deacylated tRNA binds prior to its dissociation from the 
ribosome. During translation initiation, ribosomes 
identify the initiation codon on the mRNA and set the 
correct reading frame for decoding. This rate-limiting 
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step is carried out in different ways in the primary 
domains of cell descent. In Bacteria, the small ribosomal 
subunit interacts directly with the mRNA by base-pairing 
of the Shine-Dalgarno (SD) motif, preceding the 
initiation codon, with the anti-SD motif at the 3’ end of 
16S rRNA. The initiation step is assisted by three protein 
factors, IF1, IF2 and IF3 (Gualerzi and Pon, 1990). In 
eukarya, selection of the initiation codon entails a 
“scanning” mechanism, whereby the 40S subunit binds to 
the capped 5’ end of the mRNA and then slides 
downstream until the initiator AUG, usually the first one 
available, is encountered (Kozak, 1983). This process is 
promoted by many factors, several of which are involved 
in cap recognition and mRNA unwinding, while others 
interact with the ribosome and/or the mRNA to ensure 
correct selection of the initiation codon (Pestova and 
Kolupaeva, 2002). 
1.4 Archaeal protein synthesis 
In Archaea, the absence of a nuclear membrane does 
provide the opportunity for ribosomes to bind to a 
transcript and to initiate translation before the transcript 
is complete, and this could be a positive feature of being 
a prokaryote. (Martin and Koonin, 2006). Coupling of 
transcription and translation has been documented and 
studied extensively in Bacteria, where it provides the 
molecular basis for regulation of gene expression by 
attenuation (Grundy and Henkin, 2006). It seemed 
reasonable to predict that Archaea would also have 
exploited the regulatory opportunities offered by 
coupling transcription and translation. Archaeal genome 
sequences and northern blot results do argue 
convincingly that many archaeal genes are co-transcribed 
as members of multigene operons, but only one putative 
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attenuator has been identified, and this seems likely to be 
regulated by a riboswitch rather than by a translating 
ribosome (Rodionov et al, 2003). Furthermore, archaeal 
genomes do not encode detectable homologues of the 
transcription termination factor rho (ρ) nor have 
functionally equivalent termination factors been 
identified. Furthermore, although archaeal RNA 
polymerases do exhibit intrinsic termination, they 
terminate in response to DNA template sequences 
without an apparent requirement for nascent transcript 
folding (Santangelo and Reeve, 2006). Evidence for 
coupled transcription and translation in Archaea was 
provided by electron microscopic examination of 
chromatin extruded from archaeal cells of the marine 
hyperthermophile Thermococcus kodakaraensis, which 
clearly revealed the presence of polysomes containing up 
to 20 adjacent ribosomes attached directly to dispersed 
strands of the archaeal genomic DNA. The polysome 
patterns were consistent with the sequential direct 
binding of ribosomes to nascent mRNAs. It is noteworthy 
that, although many archaeal genes are preceded by 
Shine-Dalgarno sequences functioning as ribosome-
binding sites, a large proportion of archaeal trascripts, 
especially in certain species, have no leader sequence at 
all or only very short ones (Torarinsson et al, 2005).  
Initiation of protein synthesis consists of several 
interrelated events that take place before the formation of 
the first peptide bond. The main goal of this step is the 
correct selection of the first codon on the mRNA by 
means of a specialized initiator tRNA (tRNAi), which 
becomes adapted in the ribosomal P site, ready to accept 
the next amino acid. Initiation terminates with the joining 
of the two ribosomal subunits, which allows the 
elongation phase to begin. In Archaea, two different 
21 
 
mechanisms for translational initiation exist. One is 
based on a canonical SD/ anti-SD interaction and 
operates mostly on internal cistrons of mRNAs. In 
contrast, monocistronic mRNAs as well as proximal 
cistrons of polycistronic mRNAs, which are frequently 
devoid of a 5’-untranslated region, are decoded by an 
initiation mechanism independent of the SD/anti-SD 
interaction, which requires pairing of the start codon with 
initiator-t RNA (tRNAi) (Benelli et al, 2003). The 
complexity of archaeal translational initiation is 
underscored by the presence of a larger-than-bacterial set 
of initiation factors. All archaeal genomes encode about 
10 proteins homologous to eukaryal initiation factors 
(Dennis, 1997).  One prominent example is the factor that 
adapts tRNAi in the ribosomal P site. This task is assisted 
in bacteria by the monomeric protein IF2, while in 
Eukarya and in Archaea it is performed by the trimeric 
complex eIF2, consisting of the α-, β-, and γ-subunits, 
none of which is homologous to bacterial IF2.  However, 
both Eukarya and Archaea possess a homologue of 
bacterial IF2, termed eIF5B, which seems to act at a later 
initiation step, promoting the joining of the 60S 
ribosomal subunit to the 40S initiation complex (Pestova 
et al, 2000). With the exception of a/eIF2, the function of 
the eukaryal-like translation initiation factors in Archaea 
is poorly understood. 
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Chapter 1. 
 
Analysis of the mechanism of aIF6 removal from S. 
solfataricus ribosomes. 
 
 
Introduction 
 
The conserved translation factor IF6  
The Archaea and the Eukarya selectively share several 
translation factors. One of these is the small monomeric 
protein (about 25 kDa) called eIF6 in eukarya and aIF6 in 
Archaea. The function of this factor has been extensively 
studied in eukaryotes, remaining however somewhat 
elusive. Much less is known about archaeal IF6.  
 
1.5 IF6 in eukaryotes 
The eukaryotic Initiation Factor 6 is a protein of 245 
aminoacids and 77% identical between yeasts and 
humans (Biffo et al, 1997). The eIF6 structure is 
organized in a peculiar cyclic, “star-like” structure named 
pentein (Fig.2). 
 
 
24 
 
 
 
 
eIF6 is formed by five stretches of quasi-identical 
alpha/beta-sub domains arrayed around a fivefold axis of 
pseudo-symmetry. It is a rigid protein, with a cavity that 
contains 16 well-ordered water molecules with a limited 
degree of motility. The semi-conserved carboxy-term 
was proposed as a candidate region for eIF6 regulation 
due to its flexibility (Groft et al, 2000). Accordingly, the 
carboxy-term of eIF6, in mammalian cells, is 
characterized by the presence of several phosphorylation 
sites whose significance is not totally understood. In 
Archaea, IF6 has a very similar structure, lacking 
however the C-terminal tail (Fig.2). 
eIF6 is able to bind the 60S ribosomal subunits and 
prevent their joining to the 40S ribosomal subunits. 
Fig. 2.  Pentein structures of aIF6  
and eIF6. a), RIBBONS drawing of 
M. jannaschii aIF6 (top), with a, 
black pentagon denoting the five-
fold  pseudosymmetry axis.  
Individual aIF6 subdomains are 
colour coded in progression from 
the N-terminus as follows: 
 A, red; B, yellow; C, green; D, 
blue; E, purple. b), Cα backbone 
traces of the M. jannaschii aIF6 
(black) and S. cerevisiae eIF6(gold) 
overlaied to show local differences. 
 (Source: adapted from Groftet al. 
(2000) in Nature structural biology 
7(12): 1156-1164.  
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(Valenzuela et al, 1982). The main interaction partner of 
eIF6 on the 60S, is the ribosomal protein rpL23. The C-
terminus of rpL23 mediates the interaction with the 
major binding surface of eIF6. (Klinge et al, 2011). Also, 
the neighboring ribosomal protein rpL24 and the highly 
conserved sarcin-ricin loop (SRL) contribute to the 
interaction of 60S with eIF6. In conclusion, all data 
converge on demonstrating that eIF6 binding to the 60S 
impedes 40S recruitment, thus preventing premature 80S 
formation. Therefore, to promote translation, a regulated 
mechanism for eIF6 release is required. 
Two mechanisms have been proposed for eIF6 release in 
eukaryotes. One relies on the fact that eIF6 interacts in 
the cytoplasm with RACK1, a receptor for activated 
protein kinase C(PKC). External stimuli activate the PKC 
cascade that leads to eIF6 phosphorylation through 
RACK1. Phosphorylated eIF6 is released from 60S 
subunits, with the final result of ribosome activation. 
Another described mechanism for eIF6 release is based 
on the joint action of the Sdo1/SBDS protein and of the 
elongation-factor-like protein EFL1. The former 
stimulates 60S-dependent GTP hydrolysis by EFL1, with 
consequent release of eIF6 and formation of actively 
translating 80S ribosomes. Specifically, SBDS and EFL1 
jointly evict the anti-association factor eIF6 from the 
intersubunit interface of 60S ribosomal subunits to allow 
ribosomal subunit joining. Notably, SBDS mutations that 
uncouple GTP hydrolysis from eIF6 release cause the 
Shwachman-Diamond syndrome after which the protein 
is named (Finch et al, 2011).  
The two proposed mechanisms are not mutually 
exclusive. They may act in different cell lines or in 
specific physiological situations. 
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Notably, eIF6 localizes both in the nucleolus, where it is 
enriched on the perinucleolar region, and in the 
cytoplasm (Lebreton et al, 2006). The presence of eIF6 in 
the nucleolus supports a role in ribosome biogenesis. In 
Saccharomyces cerevisiae, the ribosome biogenesis 
pathway begins with transcription of the 35S and 5S 
ribosomal RNA (rRNA) precursors by RNA polymerases 
I and III, respectively. The association of ribosomal 
proteins and pre-ribosomal factors with nascent pre-
rRNA originates a 90S pre-ribosomal complex. The 90S 
complex separates into a pre-60S complex, which in turn 
generates the large ribosomal subunit containing mature 
25S, 5.8S and 5S rRNAs and a pre-40S complex, which 
gives rise to the small ribosomal subunit containing 18S 
rRNA (Lempiainem, 2009). In agreement with its 
proposed role in ribosome biogenesis, eIF6 is found in 
large molecular weight complexes of 60S pre-ribosomes 
(Volta et al., 2005). In mammals, however, most of eIF6 
is present in the cytoplasm (Sanvito et al., 1999).  
The above observations have led to propose that 60S 
subunits carrying eIF6 would be the newly synthesized 
ones, just shipped to the cytoplasm. eIF6 release would 
be the last step of subunit maturation, that would act also 
as a sort of quality control. 
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1.6 EFL1 and SBDS/Sdo1 function in eIF6 release 
 
The elongation-factor like GTPase EFL1, that is required 
for the release of eIF6 in yeast, is highly homologous to 
eEF2. It has been shown that EFL1 can compete with 
eEF2 for ribosome binding resulting in inhibition of the 
eEF2’s ribosome associated GTPase activity. Therefore, 
it is safe to assume that they share a similar binding site 
that is known for eEF2 to be the canonical translation 
factor binding site.  
EFL1 has the basic organization of a translocation factor 
composed of the G domain (domain I) and domains II–V 
(Fig. 3). The G domain that binds and hydrolyses GTP 
consists of five highly conserved motifs (boxes G1–G5). 
Both the relative position of the boxes within the G 
domain and the residues known from thecrystal structures 
to be involved in the interactions with GTP are conserved 
in EFL1 (Fig.3A) (Berchtoldet al,1993; Czworkowski et 
al, 1994). A distinguishing feature of EFL1 is the 
presenceof a 160 aminoacid insertion between the G 
domainand domain II that has no equivalent among other 
EF 2-like factors (indicated in yellow in Fig. 3); 40% 
ofthis insertion consists of small stretches of acidic/serine 
residues. Deletion of the insertion domain results in 
athermosensitive phenotype. Homologs of EFL1 are 
present in Homo sapiens, Arabidopsis thaliana, 
Drosophila melanogaster, and Schizosaccharomyces 
pombe, indicating that the protein is highly conserved. 
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Figure 3. EFL1 is a G protein homologous to the family of EF-
2/EF-G translocases.Diagram of the primary structure of EFL1 
from S. cerevisiae. The five domains defined by the crystal structure 
of EF-G from T. thermophilus are color coded as follows: domain I 
(G domain in black), domain II (red), domain III (green), domain IV 
(blue), and domain V (orange). Open arrowheads indicate functional 
residues from the G4 and G5 boxes that are involved in guanine base 
recognition. Closed arrowheads indicate conserved amino acids 
involved in salt bridge formation between domains I and II. The 
highlighted tryptophan (position 239 in EFL1p) was found to be 
important for the interaction with the ribosomal RNA sarcin/ricin 
loop. The 160-amino acid insertion within domain II is indicated in 
yellow.  
 
Cryo-EM, biochemical and genetic analyses permitted to 
propose a mechanism for eIF6 release (Fig. 4). The 
model is based on a cofactor-dependent conformational-
switching mechanism in which EFL1 initially binds to 
the GTPase center, in direct contact with SBDS and eIF6, 
in a low-affinity, inactive GTP-bound state (Fig. 4a). 
Competing with SBDS for an overlapping binding site, 
EFL1 domain V promotes a 180° rotational displacement 
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of SBDS domain III away from the P-stalk base (closed 
state) toward helix 69 (open state), causing the SBDS 
protein to adopt a conformation that is probably 
stabilized by interactions between SBDS residues K151 
and R218 and helix 69(Fig. 4b). In the open state, SBDS 
drives the equilibrium of GTP-bound EFL1 toward an 
active high-affinity ('accommodated') SRL-bound 
conformation that effectively competes with eIF6 for an 
overlapping binding site on the SRL and promotes eIF6 
displacement from the 60S subunit (Fig. 4c). In the final 
step of the catalytic cycle, the interaction of EFL1 with 
the SRL promotes GTP hydrolysis, thereby shifting the 
EFL1 conformational equilibrium from a high- to a low-
affinity ribosome binding state and promoting 
dissociation of both EFL1 and SBDS from the 60S 
subunit (Fig. 4d). 
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Figure 4. Mechanism of eIF6 release by SBDS and EFL1. (a) 
SBDS (closed state) is recruited to a late cytoplasmic eIF6-loaded 
pre-60S subunit (b)EFL1–GTP binds directly to SBDS and eIF6 in 
the GTPase center, thus promoting rotational displacement (180°) of 
SBDS domain III away from the P-stalk base toward helix 69 (open 
state), which is stabilized by SBDS residues K151 and R218. (c) 
GTP-bound EFL1 in the accommodated state competes with eIF6 for 
an overlapping binding site on the 60S subunit, thus promoting eIF6 
displacement. (d) Interaction of EFL1–GTP with the SRL promotes 
GTP hydrolysis, thus triggering a conformational switch in EFL1 
that promotes a low-affinity ribosome binding state. SBDS and 
EFL1–GDP dissociate from the 60S subunit.  
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1.7 IF6 in Archaea 
All archaeal genomes possess a horthologue gene of 
eIF6. The Archaeal and eukaryal IF6 proteins share a 
considerable degree of homology in their primary 
sequence and have the same tertiary folding (Fig.2), 
suggesting that they share a core function conserved in 
the eukaryal/archaeal line. The function of aIF6 has been 
much less studied than that of its eukaryal homologue, 
however the available data suggest a marked functional 
similarity between the two proteins. 
Sulfolobus solfataricus aIF6(aIF6) acts as a translational 
inhibitor by binding specifically to the large ribosomal 
subunit and impairing the formation of 70S particles. 
That aIF6 may function also in vivo as a translational 
repressor under unfavourable conditions is suggested by 
the fact that it is over-expressed upon both cold-and 
heatshock (Benelli et al, 2009). It is, instead, doubtful 
whether aIF6 has a function in ribosome synthesis as 
proposed for its eukaryal counterpart. Firstly, aIF6 is 
expressed at about the same level in different growth 
phases of S. solfataricus cells, while a ribosome synthesis 
factor is expected to be up regulated during exponential 
growth.Secondly, aIF6 is over-expressed upon thermal 
shock, a circumstance in which most ribosomal genes are 
down regulated. Thirdly, aIF6 is present in sub-
stoichiometric amounts with respect to the 50S subunits 
(about 1:10), but the aIF6 binding site remains available 
on the entire cellular pool of large ribosomal particles, 
which is not expected if aIF6 dissociation is a final step 
in large subunit maturation.  
These data suggest that the protein may have evolved in 
the archaeal/eukaryal lineage to fulfil a main role in 
translational regulation. Eukaryal IF6 may then have 
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acquired additional functions during the evolution of the 
eukaryotic domain. However, like its eukaryal 
counterpart, aIF6 is tightly bound to the large ribosomal 
subunit, and must be released for the subunit to be active 
in translation. My work addresses the possibile 
mechanism whereby such release is carried out. 
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2. MATERIALS AND METHODS 
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2.1 Preparation of S. solfataricus cellular extracts and 
other cellular fractions 
About 5 g of frozen Sulfolobus solfataricus cells were 
disrupted by grinding with 10 g of alumina powder while 
gradually adding 2.5 ml/g wte weight of cells of 
ribosome extraction buffer (20 mM Tris-HCl pH 7.4, 10 
mM Mg(OAc)2, 40 mM NH4Cl, 1 mM DTT, 2.5 µg/ml 
RNase-free DNase). Alumina and cellular debris were 
removed by centrifugation twice at 30,000x g for 30 min. 
The clarified supernatant obtained (S-30) was stored at -
80°C and total protein concentration, determined by 
Bradford assay, was in the range of about 20-25 mg/ml 
according. 
Crude cellular lysates (S30) were centrifuged in a 
Beckman Ti 50 rotor at 100,000x g and 4° C for 3 h to 
separate ribosomes from a supernatant (S-100) 
containing total cellular tRNAs and ribosome-free 
cytoplasmic proteins. 
Unfractionated tRNA from S. solfataricus was prepared 
performing a phenol extraction of the crude S-100 
fraction and precipitating the aqueous phase with 2.5 
volumes of 95% ethanol.The RNA pellet was 
resuspended in 10 mM glycine pH 9.0 and the solution 
was incubated 2h at 37 °C to achieve alkaline deacylation 
of the tRNA therein contained. Lastly, the RNA was 
again precipitated and the resulting pellet was dissolved 
in an adequate volume of 10 mM Tris-HCl (pH 7.5). 
The pellet of ribosomes (termed crude ribosomes) was 
further purified by resuspending in buffer (20 mM Tris-
HCl pH 7.4, 500-mM NH4Cl, 10-mM Mg(OAc)2, 2 mM 
dithithreitol and applying on 18% (w/v) sucrose gradient 
in the same buffer to centrifuge in a Beckman Ti 50 rotor 
at 100,000x g for 6 h at 4°C. 
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The final pellets containing some amount of certain 
translation factors (e.g., aIF6), was resuspended in 
extraction buffer. This preparation represents the purified 
ribosomes. In order to devoid of translation factors 
ribosomes, these purified ribosomes were resuspended in 
a high salt buffer. The ribosome suspension was stirred 
on ice for ~1 h to allow the release of the nonribosomal 
proteins. The mixture was then layered onto a 7.0-ml 
cushion of 0.5 M sucrose made in high-salt buffer and 
centrifugated in a Beckman Ti 50 rotor operated at 
45,000 rpm for 3 hours (4°C). The ribosome pellet 
(termed “high-salt-washed ribosomes”) are lastly 
resuspended in ribosome extraction buffer containing 
10%(v/v) glycerol. 
The concentration of the ribosomes was determined by 
measuring the A260 and using as the extinction coefficient 
1 OD260 70S =40 pmol. 
The supernatant recovered after the sedimentation of the 
high-salt-washed ribosomes was supplemented with 70% 
(final concentration) ammonium sulphate and placed on 
ice for ~ 1 h to allow protein precipitation. 
The precipitate was collected by centrifuging 10 min at 
15,000 rpm; the pellet was dissolved in resuspending 
buffer (20 mM Tris-HCl pH 7.4,2 mM dithithreitol, 10% 
glycerol) and dialyzed against the same buffer. This 
preparation was the high-salt ribosome wash (HSW). 
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2.2.1 Cloning of aSdo1 gene 
 
In order to clone the aSdo1gene, two synthetic DNA 
oligomers were constructed on the sequence of S. 
solfataricus(Sso0737), the homologous of Sdo1, as 
deduced from the published genome sequence. The 
primers permitted us to clone the gene by PCR 
amplification; the forward aSdo1 is 5’-
TTTTTTTATGCTAGCATGACGAAGGAGCGTGATT
ATG-3’; the reverse aSdo1 is 5’-
CATGGTATGCTCGAGTCATCTCACTTGCAATACT
TTAAC-3’. Furthermore, the forward and reverse 
primers contained the XhoI and NheI sites respectively, 
which allowed insertion of the gene into the NheI/ XhoI 
sites of expression plasmid pRSETB (+) (Novagen). The 
vector adds to the N-terminus of the protein a tag of six 
histydine residues and the transcription of the cloned 
gene is directed by the promoter of phage T7. To 
ascertain the correct cloning of the gene, the purified 
recombinant vector was sequenced. 
2.2.2 Preparation of recombinant aSdo1 under native 
conditions. 
 
E.coli strains BL21, whose genome carries the RNA 
polymerase T7 gene under the control of lac UV5 
promoter, were transformed with the plasmid vector 
pRSETB(+)-His6-aSdo1 and grown at 37°C in LB 
medium containing ampicillin(100 µg/ml). Expression 
was induced at OD=0.6 with 1 mM isopropyl-D-
thiogalactopyranoside (IPTG) and the cells grown for a 
further 3 hours before harvesting. The cell pellet was 
resuspended in Lysis buffer (50 mM NaH2PO4, 300 mM 
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NaCl, 10 mM imidazole, pH 8.0) and incubated with 
lysozyme on ice for 30 minutes.  
The cells were lysed by sonication and the lysate was 
clarified by centrifugation at 5000 rpm for 20 minutes at 
4°C. Thermostable His6- aSdo1 was purified from the 
lysate incubating overnight on Ni-NTA agarose resin 
(Qiagen), washing with Wash buffer (50 mM NaH2PO4, 
300 m M NaCl, 20 mM imidazole, pH 8.0) and eluting 
with Elution buffer (50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole, pH 8.0).Then, this preparation was 
dialyzed against Storage buffer (20 mM TEA pH 7.4, 10 
mM KCl, 10% glycerol) and the concentration of the 
samples was determined by the Bradford assay. Aliquots 
of protein were stored at -80°C. 
 
2.3.1 Cloning of aEF2 gene. 
 
To clone the aEF2 gene, two synthetic DNA oligomers 
were constructed on the sequence of S. 
solfataricus(Sso0728) as deduced from the published 
genome sequence. The primers permitted us to clone the 
gene by PCR amplification; the forward aEF2 is 5’-
TTTTTCCATGGCTTGCCTAGATATAAGACAGTAG
AGC -3’; the reverse aEF2 is 5’- 
TTTTTGGATCCTCACGACAAGAAATCTTCCACTT
TTGGC                     -3’. Furthermore, the forward and 
reverse primers contained BamHI and NcoI sites, 
respectively, which allowed insertion of the gene into the 
NcoI/BamHI sites in correspondence of the MCS carried 
by the expression plasmid pETM11(+) (Novagen). 
Specifically, this vector adds a tag of six histydine 
residuesto the C-terminus of the recombinant proteinand 
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the transcription of the cloned gene is directed by the 
promoter of phage T7. To ascertain the correct cloning of 
the gene, the purified construct was sequenced. 
 
2.3.2 Preparation of recombinant aEF2 under native 
conditions. 
 
E.coli strains BL21, whose genome carries the RNA 
polymerase T7 gene under the control of lac UV5 
promoter, were transformed with the plasmid vector 
pETM11(+)-His6- aEF2 and grown at 37°C in LB 
medium containing kanamycin (30 µg/ml). Expression 
was induced at OD=0.6 with 1 mM isopropyl-D-
thiogalactopyranoside (IPTG) and the cells grown for a 
further 3 hours before harvesting. The cell pellet was 
resuspended in Lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH 8.0) and incubated with 
lysozyme on ice for 30 minutes.  
The cells were lysed by sonication and the lysate was 
clarified by centrifugation at 13000 g for 20 minutes at 
4°C. Thermostable His6- aEF2 was purified from the 
lysate incubating overnight on Ni-NTA agarose resin 
(Qiagen), washing with Wash buffer (50 mM NaH2PO4, 
300 m M NaCl, 20 mM imidazole, pH 8.0) and eluting 
with Elution buffer ( 50 mM NaH2PO4, 300 mM NaCl, 
250 mM imidazole, pH 8.0). 
Then, this preparation was precipitated by adding 
NH4(SO4)2 and dialyzed against Storage buffer (20 mM 
Tris/HCl pH 7.4, 10 mM KCl, 10% glycerol. The pellet 
was resuspended in a suitable dialysis buffer (30 mM 
NH4Cl, 20 mM Tris/HCl, pH 8.0, 5% glycerol; finally, 
the concentration of the samples was determined by the 
Bradford assay. Aliquots of protein were stored at -80°C. 
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2.4 Polysomal profiles 
 
Ribosomes from S. solfataricus were layered on top of a 
linear 10-30% (w/v) sucrose gradient containing 1M 
Tris-HCl pH 6.8, 1M KCl, 1M Mg(OAc)2. Reactions 
were incubated at 65°C for 10 min. After the gradients 
were centrifuged at 4°C in a SW41 Beckman rotor for 
18,000 rpm overnight and unloaded. Fractions (0,5 ml) 
were collected in 18 tubes and precipitaded with TCA-
DOC. To one volume of protein solution add 1/100 
volume of 2% DOC (Na deoxycholate detergent). We 
vortex the sample and let sit for 30 minutes at 4°C. We 
add 1/10 of Trichloroacetic acid (TCA) 100%, vortex and 
let sit over night at 4°C. Subsequently we spin at 15000g 
for 15 minutes at 4°C, carefully discard supernatant and 
retain the pellet. Wash the pellet twice with cold 100% of 
acetone. At this point we do dry the pellet and we prepare 
the samples for SDS-PAGE resuspending in a minimal 
volume of sample buffer.   
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2.5 Western blotting analysis 
The protein levels were analyzed by Western blot. Before 
electrophoretic analysis, the total protein concentration in 
cell lisates was determined by Bradford assay. Then, 
each recombinant protein was loaded on SDS-
polyacrylamide gels under reducing conditions. After 
electrophoresis, the proteins were electroblotted onto 
nitrocellulose membranes (Amersham Protran); then, the 
membranes were incubated overnight with primary 
antibody after blocking. Membranes were developed 
using the enhanced chemiluminescence method (ECL 
Western Blotting Substrate, Pierce). The bands were 
quantified by densitometric analyses using Image Lab 
program (Bio-rad) and the total amount of proteins were 
visualized by Comassie Blue R-250 staining. To reveal 
both the aSdo1 and the aEF2 proteins, the primary 
antibody used was Penta-His-antibody (Qiagen). 
 
2.6 GTPase assay 
It is an assay of inorganic phosphate in which the 
phosphomolybdate complex is reduced by ascorbic acid 
consisting in a mix of Ammonium Molybdate-Sulfuric 
Acid solution,5%. The reagents used for determination of 
phosphate were: 1 part of ascorbic acid,10% to 6 parts of 
0,42% Ammonium Molybdate.4H2O in 1 N H2SO4. We 
add 0,70 ml of the mix (called also Ames reagent) to 0,30 
ml of the phosphate solution and incubate 20 minutes at 
45°C. Before the incubation, we prepared aliquots in a 
reaction volume of 50 µl in the presence of 100 mM 
Tris/HCl pH 7.4, 100 mM MgCl2, 100 mM KCl, 100 mM 
GTP. The readings at 660 nm(UV) are proportional to 
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phosphate concentrations to an optical density of at least 
1.8. We monitored the amount of inorganic phosphate 
released after the GTP hydrolysis at 65°C at different 
times. 
 
2.7 Size-exclusion chromatography(SEC) 
The size-exclusion or gel filtration chromatography is 
a technique in which molecules in solution are separated 
by their size, and in some cases molecular weight.An 
aqueous solution is used to transport the sample through 
the column. The chromatography column is packed with 
fine, porous beads, which are composed of dextran 
polymers (Sephadex). The pore sizes of these beads 
allows to estimate the dimensions of macromolecules of 
our interest.Small molecules diffuse freely into the pores 
and their movement through the column is retarded, 
whereas large molecules are unable to enter the pores 
and are therefore eluted earlier. Hence, molecules are 
separated in order of decreasing molecular weight, with 
the largest molecules eluting from the column first.Allyl 
dextran-based size-exclusion gel (Sephacryl S-300) was 
used as the gel media. A gel column was prepared by 
filling the same amount of allyl dextran-based size-
exclusion gel (1 ml of gel beads) into thecolumn. After 
the gel column was equilibrated with a solution, 
aliquots of the mix reaction were applied to the colomn. 
Next, a solution was used to elute the unbound in the 
eluent. After, fractions (0,5 ml) were collected in 18 
tubes and precipitated with   TCA-DOC. To one volume 
of protein solution add 1/100 volume of 2% DOC (Na 
deoxycholate detergent). The samples were vortexed and 
let sit for 30 minutes at 4°C. Then, 1/10 of 
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Trichloroacetic acid (TCA) 100%, was added and let sit 
over night at 4°C. Subsequently, we spun at 15.000g for 
15 minutes at 4°C.The retained pellets were washed 
twice with cold 100% of acetone, dried and resuspended 
in an adeguate volume of Laemelly buffer 1x. The 
analysis of the precipitated proteins was performed by 
15% SDS-PAGE gels and detecting their presence by 
Western analysis. 
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3. RESULTS 
 
 
 
 
 
 
 
  
44 
 
3.1 70S particles are affected by the presence of aIF6 
 The anti-association and translational inhibitory action of 
S.solfataricus aIF6 is illustrated in Fig. 1. The graphs 
show that when recombinant aIF6 is added in excess to a 
cell lysate programmed for in vitro translation, the 
amount of 70S monomers in the samples decreased with 
increasing amounts of added protein (Benelli et al., 
2009).  
 
 
 
 
 
 
 
  
aIF6 
Fig. 1. Excess aIF6 impairs 70S formation. 20 µl of lysate 
were incubated with increasing amounts of aIF6 at 73°C for 15 
minutes. At the end of reaction, the samples were loaded on 
sucrose density gradient and, after centrifugation, the 
ribosome profile was checked.  
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In Sulfolobus, most of cellular aIF6 is in a 60S-ribosome-
bound state. The aIF6-ribosome interaction is very 
strong, as shown by the fact that the factor cannot be 
removed with high-salt washing procedures routinely 
used to free the ribosomes of extrinsic, loosely-bound 
proteins (Benelli et al, 2009). We presume, therefore, 
that aIF6 must be released by some specific mechanism 
as it happens in the eukaryotes, and that this mechanism 
would serve to regulate the access of large ribosomal 
subunits to the elongation cycle. 
 
 
3.2 Cloning of S.solfataricus aSdo1 
 
It is known that all archaeal genomes contain a 
homologue of eukaryotic SBDS, the factor required for 
eIF6 release from ribosomes. Therefore, we wished to 
learn whether the archaeal SBDS homologue (termed 
aSdo1 here) had a similar function. To obtain some 
insight about this problem, we decided to clone the S. 
solfataricus aSdo1 gene and to obtain the relative 
purified recombinant protein using conventional 
overexpression/purification systems. On the basis of the 
genome sequence of S. solfataricus, a couple of PCR 
primers were designed to amplify the aSdo1 gene by 
PCR. The product of the reaction was inserted into an 
expression vector (pRSETb+) that added a (His6)-tag to 
the C-terminus of the protein, whose transcription was 
directed by the T7 promoter. The construct was then 
expressed in E. coli BL21(DE3) strain, whose genome 
carries the RNA polymerase T7 gene under the control of 
a lac UV5 promoter. Gene expression was induced by 
IPTG; after 3 h of induction, the amount of expressed 
protein was sufficient for subsequent purification.  The 
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aSdo1protein was purified from E. coli extracts under 
native conditions and through affinity chromatography 
on a Ni2+agarose column that binds selectively the His6-
tagged protein. (Fig. 2). 
 
 
 
Fig. 2. Expression and purification of aSdo1gene was cloned in the 
pRSETb+ expression plasmid and the construct was expressed in 
E.coli BL21(DE3) strain. At the end of expression, the recombinant 
protein was purified by Ni2+agarose columns. The product of 
purification was loaded on 15% SDS-PAGE and stained with 
Coomassie M, molecular weight marker; 1-3) Increased amount of 
recombinant aSdo1corresponding to 50, 100 and 150 pmol, 
respectively.The arrow indicates the recombinant protein aSdo1. 
 
The recombinant aSdo1 was firstly used to prepare 
specific antibodies, which were employed to determine 
the cellular distribution of the protein. To this end, the 
S.solfataricus S-30 extract was fractionated on sucrose 
density gradient and the position of the factor with 
aSdo1
M    1      2     3
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respect to the ribosomes was monitored by Western blot 
with anti-His antibodies. As illustrated in Fig.3, the 
endogenous aSdo1 protein was associated with both 30S 
and 50 S ribosomes, but most of it was localized in the 
pre-ribosomal fraction. 
 
Fig. 3.Sucrose density gradient of S. solfataricus extract incubated 
with aSdo1. The reaction was layered on linear 10 to 30% sucrose 
gradients. Upper, profile of ribosome distribution along the sucrose 
gradient. The gradient fractions were checked for both absorbance at 
260 and the presence of aSdo1 with the specific antibodies (lower 
panel). 
 
Next, to determine the strength of the aSdo1-ribosome 
interaction, “crude” S.solfataricus 70S ribosomes were 
treated with 0.5 M NH4Cl (salt-wash), a procedure 
routinely employed to remove from the ribosomes any 
extrinsic, loosely associated proteins. We note that, as 
said above, high-salt washing does not dissociate aIF6 
a
30S
50S
aSdo1
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from the ribosomes. After salt-washing, the different 
fractions (salt-washed ribosomes and their supernatant 
fraction, hereinafter termed HSW) were run on gels and 
subjected to western blotting. 
The results of these experiments showed that the protein 
aSdo1 is present on crude 70S ribosomes but it is 
detached from the ribosomes when they are washed with 
high salt concentrations. (Fig. 4). We concluded that, 
unlike aIF6, aSdo1 is loosely associated with the 
ribosomes. 
 
 
Fig. 4. Western blotting for aSdo1. Lane 1, the recombinant aSdo1; 
lane 2, aSdo1 band resulted in HSW; lane 3, no band correspond to 
protein in high-salt washed ribosomes (70SHSW); lane 4, the aSdo1 
detected in 70S crude. All S. solfataricus fractions were loaded on 
15% SDS-PAGE before electroblotting onto nitrocellulose 
membrane. 
  
aSdo1
1        2          3       4
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The presence of aSdo1 on both 30S and 50S subunits was 
somewhat puzzling, as it is known that eukaryotic SBDS 
resides specifically on the 60S subunit. Since, as shown 
before, aSdo1 is not strongly associated with the 
ribosomes, it was possible that its diffuse distribution on 
the sucrose gradients was an artifact during to 
dissociation during centrifugation. To get a better insight, 
therefore, we checked the interaction of recombinant 
aSdo1 with the two purified S.solfataricus ribosomal 
subunits separately. The results clearly show that the 
factor binds specifically to the 50S subunit, while being 
incapable of interacting with the purified 30S 
particle.(Fig.5). 
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Fig. 5 Interaction 
of recombinant 
aSdo1 with the 
two purified 
S.solfataricus 
ribosomal 
subunits. aSdo1 
does not bind 30S 
subunit while 50S 
subunit is bound 
by aSdo1 until 
about 15 pmol. 
50 
 
3.3 aIF6 gets off translating ribosomes in S. 
solfataricus 
Next, we turned to investigate how aIF6 is released from 
the ribosomes.Since the factor is bound to 50S ribosomes 
not engaged in translation (as shown by the fact that it is 
not found on 70S ribosomes), it was reasonable to 
suppose that it was released once translation had begun. 
To check this, the S. solfataricus whole cell lysate (S30 
extract)was incubated at 70°C for 30 minutes under 
conditions favouring translation. After incubation, the 
lysate was fractionated on sucrose density gradient and 
the position of aIF6 was determined by western 
blotting.As shown in Fig. 6A, in the lysate programmed 
for translation about half of the total aIF6 amount was 
found off the ribosomes. Interestingly, the free protein 
consisted of multiband forms. The reason for this is as 
yet unknown, but one possibility is that the multiple 
bands represent unidentified post-translational 
modifications. 
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Fig.6 A, Lysate programmed for translation at 70°C for 30 min 
induces release of aIF6 from the 50S subunits. Furthermore, the free 
fraction of aIF6 consisted of multiband forms possibly indicative of 
uncharacterized post-translational modifications. B, crude 70S; C, in 
crude 70S, aIF6 is released only after incubation at 65°C for 10’. 
More detailed information about the mode of eIF6 
release was obtained by in vitro experiments in which 
S.solfataricus whole ribosomes, either crude or high-salt 
purified, were incubated in a variety of conditions. 
Firstly, we observed that, when crude ribosomes are 
incubated at 65° C for 10 minutes, a substantial fraction 
of bound aIF6 is released (Fig. 6B and C). This 
demonstrates that ongoing translation is not required for 
aIF6 detachment, but that the ribosomes themselves are 
competent for it. However, when high-salt washed 
ribosomes were incubated under the same conditions as 
before, aIF6 was not released (fig 7B). This suggests that 
high-salt washing removes some factor essential for aIF6 
detachment. That this is indeed the case, as shown by the 
30S
50S
70S
Lysate incubated at 70°C for 30’ aIF6
“ crude “ 70S “ not incubated aIF6
“ crude “ 70S “ at 65°C for 10’ aIF6
A) 
B) 
C) 
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fact that adding back the HSW to the purified ribosomes, 
and incubating the mixture as previously, aIF6 release 
was again observed (Fig. 7C). Importantly, the aIF6 
detachment reaction requires the hydrolysis of GTP. 
Indeed, crude 70S ribosomes incubated at 65°C for 10 
minutes with the addition of the 3 mM GMP-PNP (a non-
hydrolyzable GTP analog) blocked the release of aIF6 
(Fig.8B). This suggested that, as it happens in the 
eukaryotes, some GTPase was implicated in removing 
aIF6 from the ribosome. 
 
 
 
Fig. 7.Incubation of high salt washed ribosomes  (70SHSW)  in 
absence of recombinant aSdo1. A. 70S HSW non-incubated. B. 70S 
HSW incubated at 65°C for 10’. C. 70S HSW with HSW at 65°C for 
10’.  
  
70S HSW + HSW 65°C for 10’ aIF6
70S HSW at 65°C for 10’ aIF6
70S HSW not incubated aIF6
1      2       3      4       5     6      7       8     9      10  11   12    13    14     15   16   17    18 
50S
30S
A) 
B) 
C) 
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Fig. 8. The GMP-PNP inhibits aIF6 release from crude ribosomes.  
A) 70S + GTP at 65°C for 10’. B) 70S + GMP-PNP at 65°C for 10’.  
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3.4 Sdo1 by itself does not detach aIF6. 
In eukaryotes, eIF6 release depends upon the activity of a 
specialized GTPase, EFL1, which acts together with 
SBDS/Sdo1. Archaeal genomes, however, do not contain 
any homologue of EFL1, and in general contain very few 
putative GTPases. Two questions therefore arose: which 
was the GTPase required for aIF6 detachment in the 
Archaea? Was aSdo1 essential for aIF6 release, and did 
the eukaryotic model for such release apply to the 
Archaea? 
The involvement of aSdo1in the removal of aIF6 was 
suggested, besides the homology with the corresponding 
eukarytic factor, also by the fact that HSW ribosomes, 
which lack aSdo1, are unable to release aIF6. To 
determine whether aSdo1 could catalyze aIF6 removal, 
we incubated HSW ribosomes under different conditions, 
with and without recombinant Sdo1, and checked aIF6 
release using both centrifugation on sucrose gradients 
and size-exclusion chromatography. 
The results, shown in Fig. 9, inequivocally show that 
aSdo1, by itself, does not catalyze aIF6 detachment. 
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1      2      3     4      5     6     7      8     9      10  11   12    13    14     15   16    
30S+50S
GTP
70S not incubated aIF6
aIF670S at 65°C for 10’ 
70S HSW not incubated aIF6
70S HSW at 65°C for 10’ aIF6
70S HSW + aSdo1 65°C for 10’ aIF6
a)
c)
d)
e)
b)
Fig. 9.  Analysis of aIF6 binding to the 50S ribosomal subunits by 
size-exclusion chromatography. A) 70S not incubated. B) 70S 
incubated at 65°C for 10’. C) 70SHSW not incubated. D) 70SHSW 
at 65°C for 10’. E) 70SHSW with aSdo1 at 65°C for 10’. 
 
This result, of course, was not unexpected, since the 
required GTPase was probably lacking. In the search for 
this, we preliminarly analyzed the GTPase activities in 
the various preparations, namely crude and HSW 
ribosomes, and HSW supernatant. To this end, we 
performed non-radioactive GTPase assays, where 
hydrolysis of the nucleotide is assayed by a colorimetric 
test (see Methods). 
As shown in Fig. 10, the crude ribosome have a high 
GTPase activity, which is, however, lost upon high salt 
washing. HSW also has, as expected, the capability of 
hydrolyzing GTP. Interestingly, aSdo1by itself shows no 
capacity to hydrolyze GTP(Fig. 12), but it is apparently 
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able to act as a GTPase to some extent when incubated 
with HSW ribosomes(Fig. 11). We did not investigate 
further this point, however, since this ribosome-
dependent GTPase activity of Sdo1 is apparently not 
sufficient to cause aIF6 release. 
 
 
Fig. 10. GTPase assay at 65°C of S. solfatarucus fractions. 
Comparison between the GTPase activity at 65°C of the 70S, 
70SHSW ribosomes and HSW.   
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Fig.11. GTPase assay of 70SHSW with aSdo1 protein. GTPase 
activity at 65°C of 80 pmol 70SHSW plus 40, 80 and 160 pmol 
aSdo1 respectively. 
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Fig. 12.  GTPase activity at 65°C of a Sdo1 protein. 
Both 80 and 160 pmol aSdo1 have not a GTPase 
activity. 
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3.5 Functional characterization of aEF2 protein 
As said before, Archaea do not possess homologues of 
the specialized GTPase EFL1, involved in eIF6 release in 
eukaryotes. However, EFL1 is a close homologue of 
elongation factor 2 (EF2), which raised the possibility 
that, in Archaea, EF2 itself could be the G protein 
implicated in aIF6 detachment. 
 
To verify this surmise, we decided to clone the gene 
encoding for the aEF2 protein in our archaeal model 
organism Sulfolobus solfataricus. On the basis of the 
genome sequence of S. solfataricus, a couple of PCR 
primers were designed to amplify the aef2 gene by PCR. 
The product of the reaction was inserted into the 
expression vector pETM11+, by following the 
expression/purification of this C-terminus His6-tagged 
protein as previously described for Sdo1. Gene 
expression was induced by IPTG; after 3 h of induction, 
the amount of expressed protein was sufficient for 
subsequent purification. The aEF2 protein was purified 
from E. coli extracts under native conditions by affinity 
chromatography on a Ni2+agarose column that binds 
selectively the His-tagged protein. (Fig. 13). 
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Fig. 13. Expression and purification of aEF2. aef2 gene was cloned 
in the p ETM11+ expression vector and the construct was expressed 
in E. coli BL21(DE3) strain. At the end of expression, the 
recombinant protein was purified by Ni2+agarose columns. The 
product of purification was loaded on 12,5% SDS-PAGE and stained 
with Coomassie M, molecular weight marker; 1, with 25 pmol; 2, 
with 50 pmol;3-6, known amounts of BSA: 3,0,5 µg;4,1 µg;5, 2 µg; 
6, 4 µg. The arrow indicates the recombinant protein aEF2. 
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3.6 aEF2 catalyzes aIF6 release 
 
We checked whether recombinant aEF2 was able to 
assist aSdo1 in the removal of aIF6 from ribosomes. This 
analysis was performed by sucrose gradient 
experiments.The results, illustrated in Fig.14A, revealed 
that, in the presence of GTP, aEF2 was able to provoke 
the detachment of aIF6 by itself, in the absence of aSdo1. 
Similar results were obtained by size-exclusion 
chromatography (Fig. 15A). Moreover, this analysis was 
also performed in presence of aEF2 and aSdo1 together.  
Unexpectedly, addition of recombinant aSdo1 not only 
did not improve the release of aIF6, but actually inhibited 
it (Fig.15B).  
 
 
 
Fig. 14. aEF2 induces per se the release of aIF6 from the 50S 
subunits. A) HSW ribosomes incubated with aEF2 and GTP; B) 
HSW ribosomes incubated with aEF2 and GMP-PNP. 
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Fig. 15.Analysis of aEF2 as a GTPase involved in aIF6 release.A) 
Incubated HSW ribosomes + aEF2 + GTP. B) Incubated HSW 
ribosomes+aEF2 + aSdo1+ GTP. 
 
To get a better insight into this unexpected result, we 
repeated the experiments by incubating the ribosomes 
with Sdo1 and aEF2, but adding the proteins in a 
different order. In one sample aIF2 was added first, and 
Sdo1 after 10 min, while in another sample the reverse 
ws done. As shown in Fig.16, the addition of aSdo1 
before aEF2 effectively inhibited aIF6 release. These 
results suggest that Sdo1 and aEF2 share, at least in part, 
a common binding site on the ribosomes, and that the 
presence of aSdo1 prevents the binding of aEF2 thus 
preventing release of aIF6. 
 
A) 70SHSW + aEF2 65°C for  10’
aIF6
B) 70SHSW + aSdo1+ aEF2 65°C for  10’
30S+50S
GTP
1      2      3     4      5     6     7      8     9      10  11   12    13    14     15   16    
aIF6
aEF2
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Fig. 16.  aSdo1 inhibits the release of aIF6 induced by aEF2. A) 
HSW ribosomesincubatedwith aSdo1 and aEF2 at 65°C for 20’. B) 
HSW ribosomes incubated before with aEF2 (for 10’) and then with  
aSdo1 for another 10’. C) HSW ribosomes incubated before with 
aSdo1(for 10’) and then with aEF2 for another 10’. 
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4.DISCUSSION 
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4.1 The release of aIF6 from ribosome 
In this work, the mechanism of release of the translation 
factor aIF6 from the large ribosomal subunit has been 
experimentally studied for the first time. Although a final 
mechanism has not been defined and will require further 
work, the results obtained have unveiled interesting 
homologies and differences with the corresponding 
eukaryotic process. 
Firstly, we could conclude that aIF6 release from 
archaeal ribosomes, similar to eukaryotes, is a GTPase-
dependent event. The involved GTPase is the elongation 
factor 2 (aEF2), which by itself is necessary and 
sufficient to observe aIF6 detachment from the 
ribosomes, even in the absence of ongoing translation. 
Since Archaea do not possess a homologue of the 
GTPase EFL1, involved in the eIF6 release in eukayotes, 
a similar role of aEF2 in the process had already been 
suggested on the basis of the fact that EFL1 is a close 
homologous of eEF2.  
We found that, indeed, aEF2 was able to cause the 
release of aIF6 from the large ribosomal subunit. The 
reaction depended on the GTPase activity of the factor, 
showing that also in Archaea the detachment of aIF6 
from the ribosomes is dependent by an active, energy 
consuming, process. 
However, the archaeal aIF6 release system appears not to 
require aSdo1, the SBDS homologue. Instead, aSdo1 
seems to have an inhibitory effect on aIF6 detachment, 
probably because it binds to the ribosomes on a partially 
competitive aEF2 site. Indeed, also eukaryotic SBDS was 
shown to share in part the same binding site with the 
GTPase EFL1; however, in the eukaryotic system, the 
67 
 
arrival of EFL1 causes a conformational change of 
SBDSthat is in turn required for the ejection of eIF6. This 
does not seem to be the case in Archaea, even if further 
experimental work will be necessary to really understand 
the mechanism for aIF6 release, as well as to understand 
the role played by aSdo1 in translation. 
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Chapter 2 
 
 
Optimization of an in vitro transcription/translation 
system based on Sulfolobus solfataricus cell lysate. 
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1.INTRODUCTION 
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1.1 In vitro transcription/translation system 
At the beginning of the 1950s, several groups 
independently demonstrated that protein synthesis does 
not require the integrity of the cell and can continue after 
cell disruption. Thus, disrupted cells or their isolated 
fractions were reported to be capable of synthesizing 
proteins (Gale and Folkes, 1954). In the meantime, 
ribonucleoproteinparticles were observed and identified 
in cells and then isolatedfrom cells and studied with 
respect to their physicochemical properties (Peterman 
and Hamilton, 1957). The protein- synthesizing ability of 
these particles was experimentally proved (McQuillen et 
al,1959). The word "ribosome" wasproposed to designate 
the protein-synthesizing ribonucleoprotein particles. 
In the second half of that decade, researches conducted 
cell-free protein synthesis based on mitochondria-free 
cytoplasmicextracts of animal cells (Keller and 
Zamecnik, 1956;Littlefield and Keller, 1957). The 
dependence of the system on energy supply in theform of 
ATP and GTP was shown. 
Other researches made a real ribosomalsystem of protein 
synthesis (translation) based on human and rabbit 
reticulocytes (Bank and Marks, 1966), ascites cells 
(Keller and Littlefield, 1957) and wheat germ (Marcus 
and Feeley, 1966). Ribosomes in all ofthose systems 
were programmed with endogenous mRNA; they were 
simply readingthe messages to which they had already 
been attached at the time of cell disruption. 
Nevertheless, the significance of these systems was great, 
since theyopened the door for studies of molecular 
mechanisms of protein biosynthesis, including activation 
of amino acids, involvement of tRNA, GTP requirement, 
ribosome function and participation of soluble translation 
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factors (Zamecnik, 1969). Since the preparation 
processes did not remove messenger RNA (mRNA), the 
cellextracts that comprised early cell-free systems 
synthesized mostly native proteins from endogenous 
mRNA. These extracts were essentially supernatants 
obtained by centrifugation of lysates from disrupted cells 
e.g., at 30,000g (the so-called S30 extract) (Schweet et 
al., 1958).  
To direct the protein synthesis machinery to translate 
exogenous mRNA, the E. coli S30 extract were incubated 
in the presence of 20 amino acids and ATP regeneration 
components (Nirenberg and Matthaei, 1961). Such 
“incubated S30” improved the amount of the protein 
synthesized from exogenous mRNA, possibly by freeing 
ribosomes from attaching to endogenous mRNA 
(ribosome run-off) and allowing endogenous mRNA to 
be degraded by ribonucleases in the extract. 
Later, the coupled transcription-translation systems were 
introduced in cell-free protein synthesis using DNA as 
the template instead of mRNA (Chen and Zubay, 1983; 
Zubay, 1973). For istance, the E. coli RNA polymerase 
was used to transcribe DNA into mRNA for protein 
synthesis in the S30 extracts, mainly for the purpose of 
studying gene regulation in vitro. (Josephsen and 
Gaastra, 1985). To obtain higher amounts of mRNA, the 
researchers later used stronger phage promoters and the 
more efficient phage RNA polymerases (T7 or SP6) for 
the coupled transcription-translation from the DNA 
template (Craig et al., 1992; Krieg and Melton, 1987). In 
addition to using the more stable DNA template and 
avoiding a separate in vitro transcription step, coupled 
transcription and translation in the cell-free system often 
result in a higher protein synthesis yield, probably due to 
newly synthesized mRNA is immediately translated into 
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protein, which may minimize the adverse effects of 
mRNA degradation or inhibitory structures. 
Cell-free protein synthesis is one of widely used methods 
in molecular biology. Production of proteins using cell-
free protein synthesis usually takes a few hours, in 
contrast to production of proteins in cells, which typically 
takes days if not weeks. In fact, even first-time users can 
often obtain newly synthesized proteins on the same day 
he or she begins to use a commercial system. 
Cell-free protein synthesis (CFPS) systems derived from 
crude cell extracts have been used for decades as a 
research tool in fundamental and applied biology, as 
illustrated in Fig.1. 
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Fig.1.Cartoon comparison of in vivo recombinant DNA protein 
expression with cell-free protein synthesis (CFPS). CFPS systems 
provide a more rapid process/product development timeline. 
Example proteins shown include a virus-like particle (VLP), single-
chain antibody variable fragment(scFv) and a membrane bound 
protein (MBP). 
 
The use of cell-free protein synthesis has made the most 
impact on functional and structural genomics. For the 
first time, researchers have been able to express and 
purify a large number of proteins in a short period of time 
for subsequent high throughput functional and structural 
analyses. For instance, a number of laboratories have 
used low-cost E. coli extract and wheat germ cell-free 
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systems in high-throughput automated format to produce 
stable isotope-labeled proteins for nuclear magnetic 
resonance analyses (Aoki et al., 2009; Vinarov and 
Markley, 2005). The advantage is that only newly 
synthesized proteins are labeled during cell-free protein 
synthesis and can be analyzed without extensive 
purification. Moreover, CFPS has shown remarkable 
utility as a protein synthesis technology (Swartz, 2006), 
including the production of pharmaceutical proteins 
(Yang et al., 2005), and high-throughput production of 
protein libraries for protein evolution and structural 
genomics (Takai et al.,2010). In particular, cell-free 
systems havedistinct advantages over in vivo methods for 
recombinant protein production (Zawada et al., 2011).  
Without the need to support ancillary processesrequired 
for cell viability and growth, CFPS allows optimization 
of the cell extract towards the exclusive production of 
asingle protein product. The absence of a cell wall 
enables an open and versatile environment for active 
monitoring, rapid sampling, and direct manipulation of 
the protein synthesis process.  
In Archaea, cell-free protein synthesizing systems have 
been in use for a couple of decades, and proven to be of 
great utility for understanding the basic features of 
translation, as weel as for the synthesis of thermostable 
proteins. Most CFPS from Archaea, however, worked 
optimally with pre-synthesized mRNAs. Here, I report 
the development of a coupled in vitro 
transcription/translation system for cell-free protein 
synthesis from the thermophilic archaeon S.solfataricus. 
This system permits the efficient in vitro synthesis of 
proteins at high temperature and it is based on the use of 
an unfractionated cell lysate (S30) adapted to perform 
coupled transcription and translation. First at all, it 
85 
 
represents a powerful tool to expand our understanding 
of the molecular mechanisms governing coupled 
transcription-translation in Archaea. Moreover, the 
expression of recombinant proteins in thermophilic 
conditions similar to the native ones could facilitate the 
identification of associated factors. Furthermore, 
although mesophilic hosts such as Escherichia coli have 
been used to produce thermostable proteins for 
biochemical and crystallographic characterization (Ward 
et al., 2000; Watanabe et al., 2010), many 
hyperthermophilic proteins correctly fold only under 
physiological conditions of high temperature or in the 
presence of their native post-translational modifications. 
(Andreotti et al., 1995). 
 
 
 
 
 
 
 
 
 
 
86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
 
 
 
 
 
 
 
 
2.MATERIALS AND METHODS 
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2.1 Gene constructs and in vitro transcription 
We used the plasmid pBluescript-SK(+) as a starting 
point for our subsequent constructs. Two synthetic DNA 
oligomers of 48 nucleotides were designed on the 
conserved sequence of S. solfataricus 16S/23S rRNA 
operon promoter: Promoter rRNA SSO Forward 5’-
CGAAGTTAGATTTATATGGGATTTCAGAACAAT
ATGTATAATGGGTAC-3’ and Promoter rRNA SSO 
Reverse 5’-
CCATTATACATATTGTTCTGAAATCCCATATAAA
TCTAACTTCGGTAC-3’. After annealing of the two 
oligomers, one pmol of the purified double strand 
fragment was incubated with 0.25 pmol of Kpn I digested 
pBS-SK(+) plasmid in the presence of 10 units of T4 
DNA ligase (New England BioLabs) in 25 μl of 50 mM 
Tris-HCl, pH 7.5, 10 mM MgCl2, 10 mM dithiothreitol, 1 
mM ATP, 25 μg/ml bovine serum albumin for 20 h at 16 
°C. One tenth of this reaction mixture was then used 
directly for transformation of E.coli Top 10 competent 
cells. The clone harbouring the construct with the insert 
in the correct orientation was selected after DNA 
sequencing and termed pBS-rRNAp. Successively, a 
fragment of 393 bp containing the gene termed ORF 104 
with its Shine-Dalgarno (SD) motif was amplified from 
the construct pBS800 (Condò et al., 1999) by PCR using 
the following primers: Prom-104 Xho I 5’-
TTTTTTTATCTCGAGCCGGAATAGTTGAATTAAC
AATGAAGC-3’ and Prom-104 Pst I 5’-
CATGGTATGCTGCAGTCATTGCTTCACCTCTTTA
ATAAACTCC-3’. The fragment was inserted into the 
Xho I-Pst I digested plasmid pBS-rRNAp, yielding the 
construct termed pBS-rRNAp-104. To generate the 
construct termed pBS-rRNAp-OGT, the fragment Xho I-
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Pst I was excised from the previously plasmid and 
inserted a DNA fragment of 533 bp amplified from the 
construct pQE-ogt (Perugino et al.,2012) by PCR with 
the following primers: Forward rRNA/ SsOGT Xho I 5’-
TTTTTCTCGAGTGAGGTGAAATGTAAATGAGAG
GATCTCACCATCACC-3’ and Reverse rRNA/ SsOGT 
Pst I 5’-
TTTTTTCTGCAGTCATTCTGGTATTTTGACTCCC-
3’. 
 
2.2 In vitro labeling of transcriptional activity of 
Sulfolobus solfataricus lysate  
The transcriptional activity of the S. solfataricus cell-free 
extract was tested by 32P-UTP incorporation in two 
different reaction conditions using an aliquot of the lysate 
corresponding to 100 g of total proteins. In the first 
reaction, the cell-free extract was incubated in a reaction 
volume of 50 l, in the presence of 50 mM Tris/HCl (pH 
8.0), 25 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol, 2 
mM ATP, 1 mM GTP, 1 mM CTP, 0.6 mM UTP and 100 
M [-32P] UTP (4 Ci/mmol)  in a reaction volume of 50 
l.  The reaction was carried out at 60° C for 30 min. The 
second reaction was performed  on the basis on the in 
vitro translation experiments carried out previously 
(Benelli and Londei, 2007): S. solfataricus cell-free 
extract was incubated in a reaction volume of 50 l, in 
the presence of 10 mM KCl, 20 mM Tris/HCl (pH 6.8), 
20 mM Mg(OAc)2, 2 mM ATP, 1 mM CTP, 1 mM GTP, 
0.5 mM UTP and 100 M [-32P] UTP (4 Ci/mmol). The 
reaction, in this case, was carried out at 70° C for 30 min. 
At the end of both reactions 20 U of DNase I were added 
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and incubation was extended for 30 min at 37 °C. The 
products of the reactions were extracted by phenol pH 
4.7 and precipitated with 2.5 volumes of 95% ethanol. 
The pellets were resuspended in an adequate volume of 
DEPC-treated water and divided in two aliquots. RNase 
A (20 g) was added to one of them and both aliquots 
were incubated at 37 °C for 30 min. The newly 
synthesized RNA was separated by 8,5% of non-
denaturing polyacrylamide gels and detected using both 
an Istant Imager apparatus (Pakard) and autoradiography 
film (Kodak XAR-5).  
 
2.3 In vitro translation and coupled in vitro 
transcription-translation 
The transcription-translation activity was measured in a 
final volume of 25 l and contained: 10 mM KCl, 20 mM 
Tris/HCl (pH 6.8), 20 mM Mg(OAc)2, 1.5 mM ATP, 1.5 
mM CTP, 1.5 mM GTP, 1.5 mM UTP, 3,3 g of bulk S. 
solfataricus tRNA, 5 l of 20-25 mg/ml S. solfataricus 
S30 extract (preincubated for 10 min at 70 °C) and 0,5 l 
of L-[35S]-Methionine (S.A. 1175 Ci mmol-1 at 11 mCi 
ml-1, PerkinElmer). After mixing all components, 4 μg of 
the desired mRNA or different amounts of plasmid were 
added and the mixtures were incubated at 70 °C. Whole 
cell lysates were programmed for in vitro translation with 
transcripts of S. solfataricus genes ORF 104 and SsOGT 
cloned in pBS-SK (+) plasmid downstream of T7 RNA 
polymerase promoter in the presence of ATP and GTP to 
the final concentration of 1.8 and 0.9 mM, respectively. 
The analysis of the translation products was performed 
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by loading 15 μl of the incubation mixture in 16% 
polyacrilamide/SDS gels; after the run, the gels were 
dried and autoradiographed. 
 
2.4 qPCR and RT-PCR SsOGT labeling 
At the end of in vitro transcription or coupled in vitro 
transcription-translation, total RNA was extracted twice 
from the reactions by phenol reagent (pH 4.7) and 
precipitated by adding of 2.5 volumes of 95% ethanol.  
The pellets were resuspended in an adequate volume of 
DEPC-treated water and treated with 2 U of DNase I, 
RNase-free (ThermoFisher Scientific) in an appropriate 
buffer at 37 °C for 45 min. 
0.5 μg of total RNA was retrotranscribed for relative 
qRT-PCR analysis (SensiFAST™ cDNA Synthesis Kit, 
Bioline). qPCR was performed with the Applied 
Biosystem StepOne Real-Time PCR System 
(ThermoFisher Scientific) using 1/20 of cDNA and 10 μl 
of GoTaq® qPCR Master Mix (Promega) in a final 
volume of 20 μl. Cycling parameters were: 95 °C for 2 
min, followed by 40 cycles of denaturation at 95 °C for 3 
secs, annealing/extension at 60 °C for 30 sec.  
Each mRNA expression level was calculated by 2-ΔΔ Ct 
method and normalized to endogenous aIF6 mRNA.  
qRT-PCR reaction were performed using SYBER green 
incorporation (Promega). All samples were done in 
triplicate and each condition was repeated three times. 
The following primer sequences were used for qRT-PCR:  
aIF6 Forward 5’-ATAAGCGGTAACGATAACGG-3’ 
and aIF6 Reverse 5’-
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AATCCCTTAGATTCTCCTTCAG-3’), for pBS 
(FORWARD 5’-TGGTAACAGGATTAGCAGAG-3’ 
and Reverse 5’-ACCAAATACTGTCCTTCTAGTG-3’). 
Also for semi-quantitative RT-PCR, total RNA was 
extracted from the mix reaction. 
2 μg of total RNA were retrotranscribed in a final volume 
of 25 μl with 200U M-MLV reverse transcriptase in 20 μl 
of mixture reaction for 1 h at 42 °C according to 
instructions of the supplier (Promega). The reaction 
contained 1 μM of the followed reverse primer: 5’-
GGTTTCCCGACTGGAAAGCGGGCAG-3’. At the end 
of the reaction, the final volume of the mixture reaction 
was adjusted to 50 μl and one-tenth of the RT reaction 
was PCR amplified with Taq DNA polymerase 
(Promega) for 30 secs at 95 °C, 30 secs at 60 °C and 45 
sec at 74 °C (25 cycles) with a final extension step for 7 
min at 74 °C. Reverse primers for PCR amplification 
were the same used in the RT reaction coupled with the 
following forward primers: 5’-
CGAATTCCTGCAGCCCGGGGGATCC-3’. The 
products of the reactions were separated by agarose-gel 
electrophoresis and detected by ethidium-bromide 
staining. 
 
2.5 SsOGTin vitro labeling 
In vitro expressed OGT was analyzed incubating 8 g of 
pBS-rRNAp-OGT plasmid or 200 ng of recombinant 
SsOGT with 200 μg of S. solfataricus whole cell extract 
in presence of 2.5 μM SNAP-Vista Green™substrate 
(hereinafter BG-FL) at 70 °C for 60 min. Reactions were 
stopped by denaturation and samples were subjected to 
SDS-PAGE, followed by fluorescence gel-imaging 
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analysis using a VersaDoc 4000™ system (Bio-Rad) by 
applying as excitation/emission parameters a blue 
LED/530 bandpass filter. For western blot analysis, 
proteins were transferred onto PVDF filters (Bio-Rad) 
using the Trans-Blot1 Turbo™ Blotting System (Bio-
Rad). The presence of OGT protein was revealed using 
polyclonal antibodies raised in rabbit against S. 
solfataricus OGT as primary antibodies; the goat anti-
rabbit IgG-HRP (Pierce) as secondary antibody and the 
Amersham Biosciences ECL Plus kit. Filters were 
incubated, washed and developed according to 
manufacturer's instructions. Chemiluminescent bands 
were revealed using a VersaDoc apparatus (Bio-Rad). 
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  3.RESULTS 
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3.1Analysis of in vitro transcription in the S30 fraction 
of S. solfataricus. 
Preliminary experiments wereperfo rmed in order 
toverify whether the whole cell lysate of S. solfataricus 
 
 
 
 
summarized in Table 1 and described in detail in 
Materials and Methods. 
 
Table 1: Experimental conditions 
adopted for reactions with S30 
S.solfataricus 
 
prepared according 
to described 
protocols (Benelli 
and Londei., 2007) 
was competent for 
in vitro 
transcription.  
Specifically, we 
compared the 
transcriptional 
activity of our 
system with that of 
a previously 
described 
Sulfolobus in vitro 
transcription assay 
(Reiter et al., 1990) 
testing the capacity 
of the S30 extract 
to incorporate -
32P-UTP. Salt and 
temperature 
conditions of the 
reactions are  
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In both cases, we implemented the reactions with the 
nucleoside triphosphates at the final concentration of 1 
mM each (except ATP to 2 mM) and the S30 fraction 
was prepared omitting DNase I treatment of lysate. (As 
shown in Fig. 1), both S30 extracts showed the ability to 
recruit labeled uridine triphosphate supporting the idea 
that endogenous RNA polymerase was active. However, 
the extract prepared according to our protocol had a 
higher efficiency of uridine triphosphate incorporation. 
Successively, based on a study characterizing the 
promoter for the single-copy 16S/23S rRNA gene cluster 
of the extremely thermophilic archaebacterium 
Sulfolobus(Qureshi et al., 1995), we cloned this promoter 
into the pBS-SK(+) plasmid. The construct contained the 
region of DNA upstream from the transcription start site 
of the 16S/23S rDNA gene spanning from -1 to -40 
bp(Fig. 2a). The plasmid was incubated with the S30 
extract and its transcription was analysed by RT-PCR, 
using primers annealing to a specific region of the 
plasmid downstream of the cloned gene, thus excluding 
amplification of the endogenous target. The results 
showed an efficient transcription of the plasmid 
following incubation at 70 °C (as shown in Fig. 2b). 
 
 
98 
 
 
 
Figure 1: Transcriptional activity of S. solfataricus whole cell 
extracts. In vitro transcription reactions were performed using S. 
solfataricus S30 fractions with [-32P] UTP in different experimental 
conditions, as described in Material and Methods and Table 1. 
Reaction A was incubated at 60 °C while reaction B at 70 °C. Total 
RNA was extracted from the reaction mixes and an aliquot of the 
samples was treated with Rnase A at 37°C for 30 min. The products 
of in vitro transcription were subjected to non-denaturing 
polyacrylamide gel electrophoresis and those incorporating [-32P] 
UTP visualized by autoradiography.  
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Starting from this construct, we cloned a previously well-
characterized Sulfolobus gene encoding a putative 
ribosomal protein (Condò et al., 1999), under the 
transcriptional control of the 16S/23S rDNA promoter. 
The structure of this plasmid, termed pBS-rRNAp-104, is 
shown schematically in Fig. 2c; analysis by qPCR 
showed that it was also transcribed (Fig. 2d).  Finally, the 
pBS-rRNAp-104 construct was transcribed in vitro with 
T7 RNA polymerase and known amounts of the 
corresponding purified RNA were used to draw a 
calibration curve, which was used to quantify the 
transcription reactions (as illustrated in Fig. 2e).  
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Figure 2: In vitro trascription of plasmids containing the 16S/23S 
rRNA promoter. (a) Schematic representation of pBS-rRNAp 
construct. Horizontal arrows indicate the position of primers used for 
RT-PCR analysis. (b) RT-PCR on total RNA extracted from S30 of 
S. solfataricus previously incubated with 4 µg of pBS-rRNAp 
plasmid, showing the amplified fragment of 346 bp. (c) Schematic 
representation of pBS-rRNAp-104 plasmid. The SD motif is 
evidenced in italic, while the start codon is shown in bold. (d) 
Relative amount of RNA transcribed by pBS-rRNAp-104 plasmid 
incubated into Sso S30 extract at 70°C for 1h. (e) Absolute 
quantification of pBS-rRNAp-104 transcript using the standard curve 
method. The absolute quantities of the standards were obtained 
measuring the concentration of T7 in vitro transcribed pBS-rRNAp-
104 RNA. Serial dilutions of the in vitro transcript were obtained and 
their Ct values (red dots) were compared to those unknown (blue 
dots) extrapolating the amount of copies expressed. 
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This analysis permitted us to assess the amount of in 
vitro transcribed RNA to an order of magnitude 
corresponding to ng of RNA for g of plasmid used, in 
25 l of reaction.The absolute amount of RNA 
transcribed from the plasmid pBS-rRNAp-104 obtained 
after its incubation in the in vitro transcription-translation 
system, was measured by performing RT-qPCR as 
described above and, then, comparing the Ct values 
obtained from these samples respect to a standard curve 
plotted with Ct values obtained serial dilutions of 1 μg of 
in vitro transcribed RNA (pBS-rRNAp-104).Controls 
correspond to reactions performed on RNA purified from 
samples in absence of the plasmid and from RT minus 
cDNA reactions. 
3.2 Optimization of in vitro translation conditions 
with respect to NTPs and Mg2+ ions 
Next, we investigated whether the conditions adopted for 
in vitro transcription with the S. solfataricus S30 extract 
could affect its translational activity. Specifically, we 
sought to define an optimal concentration of NTPs since 
it is well known that free nucleotides chelate a 
proportional number of Mg2+ ions, whose presence in a 
well-defined range of concentration is essential for 
translation (Nierhaus., 2014). Surprisingly, in a system 
which contains onlyMg2+ and monovalent cations such as 
K+ or NH4
+, the ribosomes will become inactivated at 
Mg2+ concentrations below 10 mM; polyamines, mainly 
spermidine (2 mM), are necessary in order to rescue the 
activity and allow the protein synthesis rate even to 
approach in vivo perfection.The optimized systems 
contain 2 to 5 mM Mg2+. It was demonstrated a genetic 
link between intracellular Mg2+ concentration and 
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ribosome amounts per cell.  (Akanuma et al., 2014).In 
other words, ribosomes represent an important reservoir 
of the total Mg2+ amount, and a reduction of the total 
ribosome content (in particular, 70S ribosomes and 
polysomes) by genetic lesions, such as deletions of 
ribosomal proteins, seems to affect the cellular Mg2+ 
content, affecting probably the free Mg2+ concentration. 
The latter assumed effect,in turn, impairs ribosomal 
subunit association and thus hampers protein synthesis. 
So, in order to define the best conditions for in vitro 
translation,we incubated the S30 extract with pre-
transcribed 104 mRNA depending from different 
concentrations of NTPs, and determined its translational 
efficiency. Indeed, increased levels of NTP in the mix 
reactions were detrimental for in vitro translation (Fig. 
3a). 
Figure 3: In vitro expression of ORF 104. 4 µg of in vitro 
transcribed 104 mRNA were translated at different concentrations of 
NTPs (a) and Mg2+ (b) for 1h in 25 µl of reaction. (c) Different 
amounts of pBS-rRNAp-104 plasmid were incubated with S. 
solfataricus whole cell extract for 60 min at 70°C in a final volume 
of 25 µl. 
However, this could be in part compensated by 
increasing the concentration of Mg2+ ions as shown in 
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Fig. 3b. On the other hand, dispensing with added NTPs 
in the mix reaction completely inhibited the activity of 
the system, since exogenous ATP and GTP are required 
as an energy source as illustrated in Fig. 3b, lane 5. 
Overall, based on the results of Fig. 3a and 3b, we chose 
to strike a balance between NTP and Mg2+ setting them at 
the final concentration of 6 and 20 mM, respectively. 
 
3.3 Transcription and translation-coupled protein 
synthesis 
We then proceeded to verify whether the previously 
established experimental conditions allowed coupled 
transcription and translation. This question was addressed 
incubating different amount of the pBS-rRNAp-104 
plasmid with the lysate at 70 °C for 1h under the 
conditions summarized in Table 1. The predicted mRNA 
was endowed with a 5’-UTR containing a SD motif 7 
nucleotides upstream from the AUG start codon of ORF 
104. As shown in Fig. 3c, the reaction yielded of a main 
protein band of about 12 kDa, corresponding to the 
expected size of the ORF 104. 
To extend the above results to other S. solfataricus genes, 
we sub-cloned the O6-DNA-alkyl-guanine-DNA-alkyl-
transferase gene (SsOGT) from the pQE-ogt construct, 
previously characterized by Perugino and colleagues 
(Perugino et al., 2012).The product of this gene is a 
thermostable protein of about 17 kDa, belonging to an 
evolutionary conserved class of proteins involved in the 
direct repair of DNA lesions caused by alkylating agents. 
DNA alkyl-transferases (AGTs or OGTs), catalyze this 
repair by a one-step irreversible mechanism, involving 
104 
 
the transfer of the alkylic group fromO6-alkyl-guanine 
orO4-alkyl-thymine to a cysteine residue in their own 
active site. For these reasons, they are classified as 
“suicide enzymes”. On the other hand, the peculiar 
irreversible reaction of AGTs, led to the setting up of a 
new protein-tag, the so-called SNAP-tagTM, which 
represents an alternative to the classical GFP-based 
systems (Gautier et al., 2008): by using a strong 
inhibitor, the O6-benzyl-guanine (O6-BG), conjugated to 
fluorescent probes. After the reaction, the probes are 
covalently bound to the protein. The construct for the 
expression of the thermophilic variant of the SNAP-tag™ 
(Visone et al., 2017) was obtained substituting the gene 
104 from the construct pBS-rRNA-104 with the 
S.solfataricus ogt gene. The structure of the construct 
termed pBS-rRNAp-OGT is shown schematically in Fig. 
4a.  
 
  
105 
 
 
Figure 4: In vitro expression of SsOGT. (a) Schematic 
representation of pBS-rRNAp-ogt plasmid. It was designed by 
introducing a DNA fragment of 522 bp containing the ogt gene into 
the Xho I- Pst I sites replacing ORF 104. The coding region starts 
with an AUG codon (bold letters) preceding a DNA region coding 
for six histidines (underlined letters) placed to the amino-terminal 
region of the SsOGT protein (bold and italic letters). DNA insert 
contains a SD motif (italic letters), retained from the ORF 104, 
located 7 nucleotides upstream from the coding region. (b) Increased 
amount of pBS-rRNAp-ogt plasmid were incubated with S. 
solfataricus whole cell extract for 60 min at 70°C in a final volume 
of 25 µl and the products of expression were resolved by 16% 
denaturing polyacrylamide gel electrophoresis. (c) Time course of 
SsOGT expression: 4 µg of pBS-rRNAp-ogt plasmid were incubated 
with S. solfataricus whole cell extract at 70°C and equal aliquotes of 
the reaction were withdraw from the mixture at the indicated times. 
(d) Graph is plotted with the values of the band intensity 
corresponding to SsOGT protein shown in (c) and quantified using 
ImageJ software (NIH). The values represent the average of three 
independent experiments. All error bars indicate SD. 
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Specifically, the strong SD motif 7 nucleotides upstream 
from the AUG start codon was retained, and preceded 
His6- coding triplets followed by the ogt open reading 
frame. As shown in Fig. 4b, the gene was expressed 
producing a main protein band of about 18 kDa, 
corresponding to the expected size of the ORF SsOGT-
His6. As a positive control, we employed an ogt mRNA 
transcribed in vitro from the T7 promoter (lane 2), which, 
as expected, was translated less efficiently than the 
mRNA directly transcribed in the reaction mix. This is 
possibly due to the different 5’-UTR of the two mRNAs, 
but it is also conceivable that when translation takesplace 
at the same time as transcription the mRNA is stabilized 
and the ribosomes may bind more easily to the translation 
start sites. To gain insight into other factors 
influencingthe efficiency of SsOGT protein expression, 
we analysed the time course of the reaction with fixed 
amount of the same construct. The highest expression 
level of the protein was observed after 60 min incubation, 
while at longer times (90 and 120 min) the efficiency 
decreased (Fig. 4c and d), as observed in other in vitro 
expression systems (Spirin et al., 1988). Furthermore, we 
tested whether the linearization of the construct could 
produce a transcriptional run-off at the end of the gene 
with a consequent increase of the product of our interest. 
This was not the case, however: samples incubated with 
the linearized plasmid failed to yield a band 
corresponding to the expected size of the ORF SsOGT-
His6 (Fig 5a). Further analysis revealed that this was due 
to degradation of the linearized plasmid in the reaction 
mix (as illustrated in Fig. 5b) similarly to results obtained 
by other authors with different cell-free coupled 
transcription-translation systems (Yang et al., 1980). 
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Figure 5: In vitro expression of ogt from linearized plasmid. (a) 
Supercoiled and linear pBS-rRNAp-ogt plasmids were incubated 
with S. solfataricus whole cell extract for 60 min at 70 °C with 35S-
Met in a final volume of 25 µl and the products of expression were 
resolved by 16% denaturing polyacrylamide gel electrophoresis. (b) 
Survival of supercoiled and linear pBS-rRNAp-ogt plasmid after 
incubation in the S-30 coupled system. The constructs were 
incubated for 60 min at 70 °C under standard conditions and then 
analysed on a 1% agarose gel Lanes: 1, non-incubated linear pBS-
rRNAp-ogt DNA; 2, non-incubated supercoiled pBS-rRNAp-ogt 
DNA; 3, linear pBS-rRNAp-ogt DNA incubated in an S-30 mixture; 
4, supercoiled pBS-rRNAp-ogt DNA incubated in an S-30.  
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3.4 Characterization of SsOGT activity 
To test whether the in vitro produced SsOGT was 
functionally active, we incubated the construct pBS-
rRNAp-OGT with the lysate at 70 ° C for 1h in presence 
of fluorescein-derivated O6-BG (SNAP-Vista Green™, 
New England Biolabs). As above mentioned, SsOGT 
catalyzes the formation of a covalent bond between the 
benzyl group of BG and a specific cysteine residue in its 
active site; in our case, by using a fluorescein-derivative 
of BG, the successful completion of the reaction renders 
the protein fluorescent. Indeed, we observed a fluorescent 
band corresponding to the expected size of the SsOGT in 
the reaction conditions adopted (as shown in Fig. 6), 
demonstrating the active state of the expressed protein.  
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The levels of in vitro expressed SsOGT were assessed by 
comparing its fluorescence with that obtained with 
known amounts of recombinant protein. The outcome of 
Figure 6. SsOGT labeling. 
SDS-PAGE of in vitro 
expressed pBS-rRNAp-ogt 
plasmid and purified SsOGT 
protein both incubated with 
the BG-FL substrate (5 µm) 
for 60 min at 70°C. The gel 
was exposed for 
fluorescence gel-imaging 
analysis, blotted and stained 
with  Coomassie blue. 
The filter was probed with 
the anti-SsOGT 
antibody(middle panel). 
Lane 1 contains 100 µg of S. 
solfataricus S30 fraction in 
presence of the BG-FL 
substrate; lane 2 contains 8 
µg of pBS-rRNAp-ogt 
plasmid in 100 µg of S. 
solfataricus S30 fraction and 
BG-FL substrate; lane 3 
contains 200 ng of purified 
SsOGT protein with 100 µg 
of S.solfataricus S30 fraction 
and BG-FL substrate; lane 4 
contains 200 ng of purified 
OGT protein with BG-FL 
substrate; lane 5 contains 
100 µg of S.solfataricus S30 
fraction; lane 6 corresponds 
to the protein marker. 
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the experiment permitted also to exclude the possibility 
that in vitro produced SsOGT was degraded after its 
translation and upon the irreversible transfer of the 
fluoresceinated-benzyl group to the active site, as 
previously demonstrated (Perugino et al., 2015).In effect, 
incubation for 60 min at 70 °C of the recombinant 
SsOGT in the S. solfataricus lysates in the presence of 
the SNAP-Vista Green™ did not affect the activity nor 
the fluorescent signal obtained (as reported in Fig. 6, lane 
3).This analysis allowed us to estimate the amount of in 
vitro translated SsOGT to an order of magnitude, 
corresponding to ca. 10-20 ng of protein produced for g 
of plasmid used, in 25 l of reaction. 
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4.DISCUSSION 
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4.1 Advantages and applications of the in vitro 
transcription/translation system 
The present study reports the development of a 
transcription/translation system for the synthesis of 
proteins at high temperature (70°C), based on an S30 
extractfrom the thermophilic crenarcheon S. solfataricus. 
The system makes use of an engineered classical pBS-SK 
plasmid, where efficient transcription is driven by a 
strong promoter, corresponding to the DNA region 
upstream from the 16S/23S rDNA gene, while translation 
is stimulated by the presence of a strong SD-motif ahead 
of the start codon of the chosen gene. The reaction works 
at the optimal temperature of 70°C and maximal protein 
synthesis is achieved after 1 h of incubation. A 
preliminary assessment of the various parameters and 
components that affect the rate and yield of protein 
synthesis was performed. We tested the system with two 
different genes, one encoding a ribosomal protein and 
another encoding SsOGT, an enzyme, whose activity was 
determined by using a fluorescent-based assay, as 
described above. The former gene had already shown to 
be efficiently translated in vitro from a pre-trascribed 
mRNA (Condò et al., 1999) and served as a starting point 
to tune the system. Transcription/translation of the ogt-
encoding gene led to an active protein, thereby 
demonstrating that it was correctly folded/modified in the 
in vitro reaction. Moreover, the possibility to use 
fluorescent substrates for this enzyme is a clear 
advantage for the quantification of the gene product, 
making this system flexible. The simplicity of the 
experimental procedure and specific activity of the 
proteins offer a number of possibilities for the study of 
structure-function relationships of proteins. In addition to 
the therapeutic and analytical approaches, a highly 
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investigated field is the industrial large-scale cell-free 
production of proteins. For istance, (wheat germand 
E.coli systems are already used as cell-free production 
platforms for vaccines and new therapeutics against 
malaria (Arumugam et al., 2014) and human 
parainfluenza virus type 3 (Senchiet al., 2013) as well as 
for cytokines and antibodies (Zawada et al., 2011; 
Zimmerman et al., 2014). Therefore, we believe that our 
system will be appropriate to a broad range of 
applications for basic and applied research. Moreover, 
the efficient production and characterization of proteins 
that are difficult to express in living cells (e.g., toxic 
proteins, several membrane proteins, some post-
translationally modified proteins) might provide novel 
functional and pharmacological insights. 
An important novelty of our system with respect to 
previous attempts described in the literature is the 
utilization of only endogenous components present in the 
cell lysate. To date, the Thermococcus kodakaraensis 
lysate is the only described system for protein synthesis 
coupled with high-temperature translation. However, it 
requires an added thermostable T7 RNA polymerase. 
(Endoh et al., 2006). Our assay is therefore an 
economically convenient alternative, since extract 
preparation is simple and inexpensive.While the present 
work describes a promising new technology mainly for 
the gene expression analysis, it is not yet usable as such 
for the in vitro scale-up production of recombinant 
proteins. To achieve this, further experiments and 
improvements are needed, for instance, by dividing the 
reaction in two compartments, one containing the 
modified extract and one containing a feeding solution 
that includes substrates such as amino acids, ATP and 
GTP, and that is renewed by continuous flow, permitting 
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substrate replenishment and by product removal. 
Moreover, it should be observed that extant-coupled 
CFPS utilize DNA in three forms: linear PCR 
product,linearized plasmid and circular plasmid. The use 
of linear PCR products has the distinct advantage of 
simplicity, since it eliminates theneed for time-
consuming cloning steps. However, circular DNA 
plasmidshave typically been preferred to linearized 
plasmids or PCR products, due to the greater 
susceptibility of linear DNAs to nucleolytic cleavage. 
Indeed, in our case, samples incubated with the linearized 
plasmid failed to yield the expected protein product due 
to degradation of the linearized plasmid in the reaction 
mix. The removal of nucleases, and/or the utilization of 
overhang extensions to cyclize PCR products, is another 
objective for the future optimization of the system. 
In conclusion, we believe that the system described here 
has very good potential for use in fields such as protein 
display technologies, interactome analysis and 
understanding of the molecular mechanisms governing 
coupled transcription-translation in Archaea. 
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